We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Aurora Diagnostics Cancels Plans for an IPO

By LabMedica International staff writers
Posted on 20 Jun 2012
Aurora Diagnostics (Palm Beach Gardens, FL, USA), a specialized diagnostics company focusing on the anatomic pathology market, canceled its long-delayed plans for an initial public offering (IPO) on June 6, 2012. More...
The company asked the US Securities and Exchange Commission (SEC) to withdraw its registration statement because it had decided not to pursue an initial public offering (IPO) or stock market launch.

In April 2010, Aurora Diagnostics was seeking to raise up to USD 150 million. Although it never set a date or price for that offering, the company updated its financial results every quarter to keep its eligibility for the offering current. It even held several conference calls for prospective investors. Aurora Diagnostics raised USD 200 million in December 2010 through a private bond placement.

Aurora Diagnostics lost USD 32.9 million in 2011 on revenue of USD 277.5 million, compared with a USD 3.7 million loss on revenue of USD 212.8 million the year before. It followed that up in the first quarter with a USD 2.1 million loss on revenue of USD 72.1 million, compared with a USD 2 million loss on revenue of USD 62.6 million in the same period a year ago.

Related Links:

Aurora Diagnostics



New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Collection and Transport System
PurSafe Plus®
New
Hemodynamic System Monitor
OptoMonitor
New
Human Estradiol Assay
Human Estradiol CLIA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.